Yaxiong Tang

1.0k total citations
42 papers, 775 citations indexed

About

Yaxiong Tang is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yaxiong Tang has authored 42 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yaxiong Tang's work include Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Yaxiong Tang is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Yaxiong Tang collaborates with scholars based in China, United States and Canada. Yaxiong Tang's co-authors include Xiaolin Zi, Anne R. Simoneau, Jun Xie, Xuesen Li, Zhongbo Liu, Bang H. Hoang, Yi Guo, Babbak Shahandeh, Mingkui Wang and John P. Fruehauf and has published in prestigious journals such as Cancer Research, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yaxiong Tang

35 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaxiong Tang China 15 436 117 111 92 88 42 775
Wenyi Jin China 19 399 0.9× 113 1.0× 111 1.0× 70 0.8× 126 1.4× 43 842
Benjaporn Buranrat Thailand 15 378 0.9× 136 1.2× 86 0.8× 46 0.5× 112 1.3× 82 791
J. K. Kundu South Korea 8 364 0.8× 148 1.3× 174 1.6× 64 0.7× 105 1.2× 10 866
Tariq A. Bhat India 14 421 1.0× 141 1.2× 102 0.9× 174 1.9× 59 0.7× 37 921
Martin Jozef Péč Slovakia 16 380 0.9× 162 1.4× 84 0.8× 66 0.7× 96 1.1× 49 825
Anqi Zeng China 17 435 1.0× 136 1.2× 131 1.2× 54 0.6× 92 1.0× 45 858
Qingdi Quentin Li China 18 393 0.9× 133 1.1× 183 1.6× 58 0.6× 44 0.5× 28 841
Te-Mao Li Taiwan 18 394 0.9× 117 1.0× 124 1.1× 45 0.5× 142 1.6× 20 877
Eliana Guerriero Italy 21 472 1.1× 150 1.3× 187 1.7× 116 1.3× 58 0.7× 35 1.2k
Huma Naz India 15 367 0.8× 92 0.8× 90 0.8× 54 0.6× 43 0.5× 50 781

Countries citing papers authored by Yaxiong Tang

Since Specialization
Citations

This map shows the geographic impact of Yaxiong Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaxiong Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaxiong Tang more than expected).

Fields of papers citing papers by Yaxiong Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaxiong Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaxiong Tang. The network helps show where Yaxiong Tang may publish in the future.

Co-authorship network of co-authors of Yaxiong Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Yaxiong Tang. A scholar is included among the top collaborators of Yaxiong Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaxiong Tang. Yaxiong Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Yaxiong, Xianyanling Yi, & Jianzhong Ai. (2025). mRNA vaccines for prostate cancer: A novel promising immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(3). 189333–189333. 1 indexed citations
2.
3.
4.
5.
Wang, Jiahao, Shan Yin, Yaxiong Tang, et al.. (2024). Association Between Physical Activity and the Prevalence of Kidney Stones in American Adults: Results From a Multiyear National Survey. Urology. 189. 9–18. 3 indexed citations
6.
Wu, Kan, Xu Liu, Yaxiong Tang, Xianding Wang, & Xiang Li. (2024). Clinicopathologic characteristics and outcomes of prostate cancer incidentally discovered at the time of radical cystoprostatectomy: a population-based cohort study. International Journal of Surgery. 110(7). 4023–4030. 2 indexed citations
7.
Tang, Yaxiong, et al.. (2023). Predictors of trimodality therapy in patients with muscle-invasive bladder cancer and effect on survival. Clinical & Translational Oncology. 26(2). 446–455. 2 indexed citations
8.
Shao, Yanxiang, et al.. (2023). Relationship between weight-adjusted-waist index and erectile dysfunction in the United State: results from NHANES 2001-2004. Frontiers in Endocrinology. 14. 1128076–1128076. 41 indexed citations
9.
Tang, Yaxiong, et al.. (2022). Clinical value of flexible ureteroscope in the treatment of upper urinary tract calculi. Minerva Surgery. 78(6). 736–739. 1 indexed citations
10.
Li, Wenhua, et al.. (2019). Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits bladder cancer cell growth via the mitochondrial apoptosis and JNK pathways. Toxicology and Applied Pharmacology. 371. 41–54. 49 indexed citations
11.
Chen, Yuwen, et al.. (2018). (−)-Gochnatiolide B, synthesized from dehydrocostuslactone, exhibits potent anti-bladder cancer activity in vitro and in vivo. Scientific Reports. 8(1). 8807–8807. 10 indexed citations
12.
Ren, Laifeng, Yao Liu, Liandi Guo, et al.. (2013). Loss of Smu1 function de-represses DNA replication and over-activates ATR-dependent replication checkpoint. Biochemical and Biophysical Research Communications. 436(2). 192–198. 12 indexed citations
13.
Wang, Jing, et al.. (2012). Flavokawain B induces apoptosis of non-small cell lung cancer H460 cells via Bax-initiated mitochondrial and JNK pathway. Biotechnology Letters. 34(10). 1781–1788. 27 indexed citations
14.
Zhang, Xiaoqiang, Fu Li, Zhigang Zhao, et al.. (2012). Diterpenoids from the root bark of Jatropha curcas and their cytotoxic activities. Phytochemistry Letters. 5(4). 721–724. 19 indexed citations
15.
Tang, Yaxiong, Anne R. Simoneau, Jun Xie, et al.. (2011). Lycopene Enhances Docetaxel's Effect in Castration-Resistant Prostate Cancer Associated with Insulin-like Growth Factor I Receptor Levels. Neoplasia. 13(2). 108–119. 66 indexed citations
16.
Mi, Jie, Xiaohou Wu, Chunli Luo, et al.. (2011). Structural features and bioactivities of the chitosan. International Journal of Biological Macromolecules. 49(4). 543–547. 33 indexed citations
17.
18.
Tang, Yaxiong, Anne R. Simoneau, Yi Guo, et al.. (2009). WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells. Molecular Cancer Therapeutics. 8(2). 458–468. 89 indexed citations
19.
Tang, Yaxiong, Anne R. Simoneau, Jun Xie, Babbak Shahandeh, & Xiaolin Zi. (2008). Effects of the Kava Chalcone Flavokawain A Differ in Bladder Cancer Cells with Wild-type versus Mutant p53. Cancer Prevention Research. 1(6). 439–451. 68 indexed citations
20.
Tang, Yaxiong, Anne R. Simoneau, John P. Fruehauf, & Xiaolin Zi. (2007). Lycopene-mediated potentiation of docetaxel on prostate cancer in vitro and in vivo is IGF-I receptor dependent. 67. 4769–4769. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenyi Jin Breakdown of academic impact, for papers by Benjaporn Buranrat Breakdown of academic impact, for papers by J. K. Kundu Breakdown of academic impact, for papers by Tariq A. Bhat Breakdown of academic impact, for papers by Martin Jozef Péč Breakdown of academic impact, for papers by Anqi Zeng Breakdown of academic impact, for papers by Qingdi Quentin Li Breakdown of academic impact, for papers by Te-Mao Li Breakdown of academic impact, for papers by Eliana Guerriero Breakdown of academic impact, for papers by Huma Naz
Rankless by CCL
2026